André Mansinho

10PUBLICATIONS
45CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMolecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 01, 2026
Integrating antibody-drug conjugates into solid tumor oncology: Current standards and future directions.

|May 23, 2026
Therapy Optimization in mHSPC: Insights from a Multidisciplinary Uro-Oncology Expert Panel.

|May 30, 2025
RANK Pathway Inhibition Sensitizes Triple-Negative Breast Cancer to CDK4/6 Inhibitors and Enhances Immune Response.

Inês Gomes, Maria Martelo, Rúben D Vilela

|Aug 26, 2023
Immunotherapy around the Clock: Impact of Infusion Timing on Stage IV Melanoma Outcomes.

Lisa Gonçalves, Duarte Gonçalves, Teresa Esteban-Casanelles

|Aug 23, 2023
Avelumab as First-Line Maintenance Treatment in Locally Advanced or Metastatic Urothelial Carcinoma.

André Mansinho, Andreia Cruz, Lorenzo Marconi

|Nov 23, 2022
Histology-Agnostic Drugs: A Paradigm Shift-A Narrative Review.

André Mansinho, Ricardo Miguel Fernandes, António Vaz Carneiro

Pageof 2

Frequent Collaborators

5 joint publications

Luís Costa

4 joint publications

Sandra Casimiro

3 joint publications

Catarina Abreu

2 joint publications

Marta Martins